CoChat

Relevance of biomarkers across different neurodegenerative diseases

Open access
Ehrenberg, Alexander J., Khatun, Ayesha, Coomans, Emma, Betts, Matthew J., Capraro, Federica, Thijssen, Elisabeth H., Senkevich, Konstantin, Bharucha, Tehmina, Jafarpour, Mehrsa, Young, Peter N. E., Jagust, William, Carter, Stephen F., Lashley, Tammaryn, Grinberg, Lea T., Pereira, Joana B., Mattsson-Carlgren, Niklas, Ashton, Nicholas J., Hanrieder, Jörg, Zetterberg, Henrik, Schöll, Michael, Paterson, Ross W. · 2020 · Alzheimer's Research & Therapy
Cited by 79

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Background: The panel of fluid- and imaging-based biomarkers available for neurodegenerative disease research is growing and has the potential to close important gaps in research and the clinic. With this growth and increasing use, appropriate implementation and interpretation are paramount. Various biomarkers feature nuanced differences in strengths, limitations, and biases that must be considered when investigating disease etiology and clinical utility. For example, neuropathological investigations of Alzheimer’s disease pathogenesis can fall in disagreement with conclusions reached by biomarker-based investigations. Considering the varied strengths, limitations, and biases of different research methodologies and approaches may help harmonize disciplines within the neurodegenerative disease field. Purpose of review: Along with separate review articles covering fluid and imaging biomarkers in this issue of Alzheimer’s Research and Therapy, we present the result of a discussion from the 2019 Biomarkers in Neurodegenerative Diseases course at the University College London. Here, we discuss themes of biomarker use in neurodegenerative disease research, commenting on appropriate use, interpretation, and considerations for implementation across different neurodegenerative diseases. We also draw attention to areas where biomarker use can be combined with other disciplines to understand issues of pathophysiology and etiology underlying dementia. Lastly, we highlight novel modalities that have been proposed in the landscape of neurodegenerative disease research and care.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13195-020-00601-w

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Cited by

See all 79

Metadata

Authors
Ehrenberg, A. J., Khatun, A., Coomans, E., Betts, M. J., Capraro, F., Thijssen, E. H., Senkevich, K., Bharucha, T., Jafarpour, M., Young, P. N. E., Jagust, W., Carter, S. F., Lashley, T., Grinberg, L. T., Pereira, J. B., Mattsson-Carlgren, N., Ashton, N. J., Hanrieder, J., Zetterberg, H., Schöll, M., & Paterson, R. W.
Venue
Alzheimer's Research & Therapy
Published
2020-05-13
Volume
12
Issue
1
Pages
56-56
ISSN
1758-9193 (ISSN-L)
OpenAlex
W3027478827
Cited by
79
References
38
FWCI
7.18
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Relevance of biomarkers across different neurodegenerative diseases. https://app.cochat.ai/papers/10.1186/s13195-020-00601-w
The paper
Ehrenberg, A. J., Khatun, A., Coomans, E., Betts, M. J., Capraro, F., Thijssen, E. H., Senkevich, K., Bharucha, T., Jafarpour, M., Young, P. N. E., Jagust, W., Carter, S. F., Lashley, T., Grinberg, L. T., Pereira, J. B., Mattsson-Carlgren, N., Ashton, N. J., Hanrieder, J., Zetterberg, H., . . . Paterson, R. W. (2020). Relevance of biomarkers across different neurodegenerative diseases. Alzheimer's Research & Therapy. https://doi.org/10.1186/s13195-020-00601-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.